---
title: Metoprolol Succinate
description: 'Metoprolol Succinate is prescribed for:'
is_banned: false
lastModified: '2025-09-22T17:21:53.609Z'
faqs:
  - q: >-
      What is the recommended dosage for Metoprolol Succinate?**


      **A:** The dosage depends on the indication and patient-specific factors.
      For hypertension and angina, it's typically 25-100 mg once daily, titrated
      to a maximum of 400 mg daily.  For heart failure, the starting dose is
      lower, and for post-myocardial infarction, the usual maintenance dose is
      190 mg once daily.
    a: >-
      A:** The dosage depends on the indication and patient-specific factors.
      For hypertension and angina, it's typically 25-100 mg once daily, titrated
      to a maximum of 400 mg daily.  For heart failure, the starting dose is
      lower, and for post-myocardial infarction, the usual maintenance dose is
      190 mg once daily.
  - q: >-
      What are the common side effects of Metoprolol Succinate?**


      **A:** Common side effects include dizziness, tiredness, bradycardia,
      hypotension, nausea, and depression.
    a: >-
      A:** Common side effects include dizziness, tiredness, bradycardia,
      hypotension, nausea, and depression.
  - q: >-
      Can Metoprolol Succinate be used in patients with asthma?**


      **A:**  Metoprolol should be used with caution in patients with asthma or
      COPD, as it can potentially exacerbate bronchospasm. Cardioselective
      beta-blockers are preferred, but close monitoring is still necessary.
    a: >-
      A:**  Metoprolol should be used with caution in patients with asthma or
      COPD, as it can potentially exacerbate bronchospasm. Cardioselective
      beta-blockers are preferred, but close monitoring is still necessary.
  - q: >-
      What are the contraindications to using Metoprolol Succinate?**


      **A:** Contraindications include severe bradycardia, second- or
      third-degree heart block, cardiogenic shock, decompensated heart failure,
      and hypersensitivity to the drug.
    a: >-
      A:** Contraindications include severe bradycardia, second- or third-degree
      heart block, cardiogenic shock, decompensated heart failure, and
      hypersensitivity to the drug.
  - q: >-
      How should Metoprolol Succinate be discontinued?**


      **A:**  The dose should be gradually tapered down over 1-2 weeks to avoid
      rebound hypertension or worsening of angina.
    a: >-
      A:**  The dose should be gradually tapered down over 1-2 weeks to avoid
      rebound hypertension or worsening of angina.
  - q: >-
      Does Metoprolol Succinate interact with other medications?**


      **A:** Yes, Metoprolol interacts with many drugs, including calcium
      channel blockers, digoxin, clonidine, and CYP2D6 inhibitors/inducers. 
      It's crucial to check for potential drug interactions before prescribing.
    a: >-
      A:** Yes, Metoprolol interacts with many drugs, including calcium channel
      blockers, digoxin, clonidine, and CYP2D6 inhibitors/inducers.  It's
      crucial to check for potential drug interactions before prescribing.
  - q: >-
      Can Metoprolol Succinate be used during pregnancy?**


      **A:** Metoprolol should be used during pregnancy only if the potential
      benefit outweighs the potential risk to the fetus.  It's categorized as
      Pregnancy Category C.
    a: >-
      A:** Metoprolol should be used during pregnancy only if the potential
      benefit outweighs the potential risk to the fetus.  It's categorized as
      Pregnancy Category C.
  - q: >-
      Is Metoprolol Succinate safe to use while breastfeeding?**


      **A:** Metoprolol is present in breast milk, but typically in small
      amounts. Infants should be monitored for potential side effects like
      bradycardia.
    a: >-
      A:** Metoprolol is present in breast milk, but typically in small amounts.
      Infants should be monitored for potential side effects like bradycardia.
  - q: >-
      How often should Metoprolol Succinate be taken?**


      **A:** Metoprolol Succinate extended-release tablets are designed for
      once-daily dosing.
    a: >-
      A:** Metoprolol Succinate extended-release tablets are designed for
      once-daily dosing.
  - q: >-
      What should I monitor in a patient taking Metoprolol Succinate?**


      **A:** Monitor heart rate, blood pressure, ECG, and signs of worsening
      heart failure.  In patients with diabetes, monitor blood glucose closely,
      as metoprolol can mask symptoms of hypoglycemia.
    a: >-
      A:** Monitor heart rate, blood pressure, ECG, and signs of worsening heart
      failure.  In patients with diabetes, monitor blood glucose closely, as
      metoprolol can mask symptoms of hypoglycemia.
---
## **Usage**

Metoprolol Succinate is prescribed for:

* **Hypertension:**  Lowers blood pressure.
* **Angina Pectoris (Chest Pain):** Prevents and treats angina attacks.
* **Heart Failure:** Improves survival rates and reduces heart failure hospitalizations in symptomatic patients.
* **Myocardial Infarction (Heart Attack):** Treatment of and secondary prevention after a heart attack.

**Pharmacological Classification:**  Metoprolol Succinate is a cardioselective beta-1 adrenergic blocking agent (beta-blocker).

**Mechanism of Action:** Metoprolol selectively blocks beta-1 adrenergic receptors in the heart, reducing heart rate, cardiac output, and myocardial oxygen demand.  This leads to decreased blood pressure and less strain on the heart.

## **Alternate Names**

* Metoprolol succinate extended-release
* Toprol XL (brand name)

## **How It Works**

**Pharmacodynamics:**  Metoprolol primarily affects the cardiovascular system by reducing heart rate, contractility, and cardiac output. It also decreases renin release and peripheral vascular resistance.

**Pharmacokinetics:**

* **Absorption:** Well-absorbed orally.
* **Metabolism:** Extensively metabolized by the liver, primarily by CYP2D6.
* **Elimination:**  Excreted primarily in the urine.

**Mode of Action:** Metoprolol competitively binds to beta-1 adrenergic receptors in the heart, preventing the binding of catecholamines (like adrenaline and noradrenaline). This inhibits the sympathetic nervous system's effects on the heart, leading to the therapeutic effects described above.

**Receptor Binding:** Selective for beta-1 adrenergic receptors.

**Elimination Pathways:** Hepatic metabolism (primarily CYP2D6) followed by renal excretion.


## **Dosage**

### **Standard Dosage**

#### **Adults:**

* **Hypertension:** Initial 25-100 mg orally once daily. Titrate weekly until optimal blood pressure control. Maximum dose: 400 mg daily.
* **Angina Pectoris:** Initial 100 mg orally once daily. Titrate weekly until optimum clinical response. Maximum dose: 400 mg daily.
* **Heart Failure:** Initial 12.5 mg (severe heart failure) or 25 mg (NYHA Class II heart failure) orally once daily. Double the dose every two weeks up to a maximum of 200 mg orally once daily.
* **Post-Myocardial Infarction:**  Long-term treatment: 190 mg once daily. Late treatment: 100 mg twice a day.

#### **Children:**
Metoprolol succinate extended release tablets are recommended for children 6 years or older with hypertension. The initial dose is 1 mg/kg orally once daily, not to exceed 50 mg daily. The dose should be adjusted according to the blood pressure response, up to a maximum of 2 mg/kg (or 200 mg) once daily. Use in children younger than 6 years old has not been established.

#### **Special Cases:**

* **Elderly Patients:** Start with a lower dose and titrate carefully.
* **Patients with Renal Impairment:** No specific dosage adjustment is typically needed.
* **Patients with Hepatic Dysfunction:** Reduce the dose as needed based on the severity of the impairment.
* **Patients with Comorbid Conditions:**  Careful monitoring is required, particularly in patients with diabetes (metoprolol can mask hypoglycemia symptoms) and other cardiovascular diseases.

### **Clinical Use Cases**

Metoprolol is typically administered orally for chronic conditions. Intravenous administration is primarily used in acute myocardial infarction. Dosage in these specific clinical settings should be guided by patient response and hemodynamic monitoring.  Consult specific guidelines for intubation, surgical procedures, mechanical ventilation, ICU use, and emergency situations. 

### **Dosage Adjustments**

Dose modifications are necessary in cases of hepatic impairment and, sometimes, in elderly patients. Genetic polymorphisms affecting CYP2D6 metabolism can also influence drug levels and might necessitate adjustments.


## **Side Effects**

### **Common Side Effects:**

* Dizziness, tiredness, fatigue
* Depression, sleep disturbances
* Nausea, diarrhea, stomach pain
* Bradycardia, hypotension
* Cold hands and feet


### **Rare but Serious Side Effects:**

* Worsening heart failure
* Severe bradycardia, heart block
* Bronchospasm (in patients with asthma or COPD)
* Liver dysfunction


### **Long-Term Effects:**
No significant long-term effects have been consistently reported other than those associated with the therapeutic effect (e.g., sustained blood pressure lowering).

### **Adverse Drug Reactions (ADR):**
Severe bradycardia, heart block, and bronchospasm requiring immediate medical attention.

## **Contraindications**

* Hypersensitivity to metoprolol.
* Severe bradycardia, second- or third-degree heart block, sick sinus syndrome (unless a pacemaker is present).
* Cardiogenic shock, decompensated heart failure.
* Severe peripheral vascular disease.


## **Drug Interactions**

Metoprolol interacts with numerous medications, including:

* **Calcium Channel Blockers (e.g., Verapamil, Diltiazem):** Increased risk of bradycardia and hypotension.
* **Digoxin:** Increased risk of bradycardia.
* **Clonidine:** Increased risk of rebound hypertension.
* **CYP2D6 Inhibitors (e.g., Fluoxetine, Paroxetine):** Increased metoprolol levels.
* **CYP2D6 Inducers (e.g., Rifampin):** Decreased metoprolol levels.
* **NSAIDs:** Reduced antihypertensive effect.
* **Alcohol:** Can potentiate the hypotensive effect.



## **Pregnancy and Breastfeeding**

**Pregnancy Safety Category:** C

**Fetal Risks:**  Although animal studies suggest potential adverse effects, data in humans is limited.  Use only if clearly needed.

**Breastfeeding:**  Metoprolol is excreted in breast milk in small amounts.  Monitor infants for potential side effects like bradycardia, hypotension, and difficulty feeding.  If concerned, discuss formula feeding with the patient.



## **Drug Profile Summary**

* **Mechanism of Action:** Beta-1 selective adrenergic blocker.
* **Side Effects:** Dizziness, fatigue, bradycardia, hypotension, nausea, depression.
* **Contraindications:** Severe bradycardia, heart block, cardiogenic shock, decompensated heart failure.
* **Drug Interactions:** Calcium channel blockers, digoxin, clonidine, CYP2D6 inhibitors/inducers.
* **Pregnancy & Breastfeeding:** Use with caution; monitor infant.
* **Dosage:** Varies depending on indication; 25-400 mg daily for hypertension and angina, up to 200 mg for heart failure.
* **Monitoring Parameters:**  Heart rate, blood pressure, ECG, signs of heart failure.

## **Popular Combinations**

Metoprolol is often combined with other antihypertensive medications like thiazide diuretics (hydrochlorothiazide) and ACE inhibitors.



## **Precautions**

* **General Precautions:** Assess for allergies, heart conditions, respiratory diseases, and liver/kidney function before initiating therapy.
* **Specific Populations:** Monitor closely during pregnancy and breastfeeding. Use with caution in elderly patients and those with hepatic impairment.
* **Lifestyle Considerations:** Advise patients to avoid alcohol, as it can potentiate the hypotensive effects. 



## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Metoprolol Succinate?**

**A:** The dosage depends on the indication and patient-specific factors. For hypertension and angina, it's typically 25-100 mg once daily, titrated to a maximum of 400 mg daily.  For heart failure, the starting dose is lower, and for post-myocardial infarction, the usual maintenance dose is 190 mg once daily.

### **Q2:  What are the common side effects of Metoprolol Succinate?**

**A:** Common side effects include dizziness, tiredness, bradycardia, hypotension, nausea, and depression.

### **Q3: Can Metoprolol Succinate be used in patients with asthma?**

**A:**  Metoprolol should be used with caution in patients with asthma or COPD, as it can potentially exacerbate bronchospasm. Cardioselective beta-blockers are preferred, but close monitoring is still necessary.

### **Q4:  What are the contraindications to using Metoprolol Succinate?**

**A:** Contraindications include severe bradycardia, second- or third-degree heart block, cardiogenic shock, decompensated heart failure, and hypersensitivity to the drug.

### **Q5:  How should Metoprolol Succinate be discontinued?**

**A:**  The dose should be gradually tapered down over 1-2 weeks to avoid rebound hypertension or worsening of angina.


### **Q6: Does Metoprolol Succinate interact with other medications?**

**A:** Yes, Metoprolol interacts with many drugs, including calcium channel blockers, digoxin, clonidine, and CYP2D6 inhibitors/inducers.  It's crucial to check for potential drug interactions before prescribing.

### **Q7: Can Metoprolol Succinate be used during pregnancy?**

**A:** Metoprolol should be used during pregnancy only if the potential benefit outweighs the potential risk to the fetus.  It's categorized as Pregnancy Category C.

### **Q8: Is Metoprolol Succinate safe to use while breastfeeding?**

**A:** Metoprolol is present in breast milk, but typically in small amounts. Infants should be monitored for potential side effects like bradycardia.

### **Q9: How often should Metoprolol Succinate be taken?**

**A:** Metoprolol Succinate extended-release tablets are designed for once-daily dosing.


### **Q10: What should I monitor in a patient taking Metoprolol Succinate?**

**A:** Monitor heart rate, blood pressure, ECG, and signs of worsening heart failure.  In patients with diabetes, monitor blood glucose closely, as metoprolol can mask symptoms of hypoglycemia.
